Lifeline Skin Care Launches Daily Defense Anti-Aging Skincare Complex Using Groundbreaking Technology and Science to Promote Rapid Rejuvenation of Damaged Cells

• 

Lifeline® Skin Care, the only line of skin care products in the world based on growth factors from human stem cells, launched its new Daily Defense Complex. The super-potent formula will firm, tone and defend skin and also integrates easily into post-procedure protocols and homecare regimens.

The proteins and growth factors that are extracted from stem cells can reduce the appearance of the signs of aging--lines, wrinkles and loss of radiance

Carlsbad, CA (PRWEB) April 10, 2014

Most baby boomers grew up not knowing about the importance of sun protection. The term SPF wasn’t even invented until 1962. So let’s blame those lines and wrinkles, age spots and skin laxity on the sun! According to the Environmental Protection Agency, as much as 90 percent of skin aging is caused by sun exposure. New ingredients are emerging that are changing the long-held belief that UV skin damage is irreversible. In fact, studies show when the skin is exposed to extracts from human stem cells it helps repair and rejuvenate itself. Lifeline® Skin Care, the only line of skin care products in the world based on growth factors from human stem cells, will launch its new Daily Defense Complex in April in spas and physician offices nationwide. The super-potent formula will firm, tone and defend skin and also integrates easily into post-procedure protocols and homecare regimens.

“Lifeline Skin Care uses growth factors that have been extracted from human stem cells,” said Simon Craw, Ph.D., of International Stem Cell Corporation, the parent company of Lifeline Skin Care. “Stem cells have the natural ability to identify and repair damaged cells. In the laboratory, we discovered how stem cells can rejuvenate many different types of cells, including skin cells. The proteins and growth factors that are extracted from these stem cells can reduce the appearance of the signs of aging--lines, wrinkles and loss of radiance.”

Dermatologists believe that women don’t get serious about anti-aging skin care until they’re in their 30’s, when fine lines and wrinkles begin to appear. “But the 40th birthday is the real game changer,” said Dr. Elizabeth Hale of Complete Skin MD in New York City. “After age 40, fine lines deepen into full fledged wrinkles, and dark spots and age spots begin to surface. It’s at this point that women start to look for more advanced and results-oriented skin care ingredients.”

Key ingredients in the new Daily Defense Complex help to repair previous photoaging and protect against future UV damage. Collagen and elastin production have been proven in vitro to increase by 46-55%. Collagen and elastin are two key proteins that make skin appear firmer and younger-looking.

Daily Defense Complex is designed for all skin types but it is particularly recommended for mature or photodamaged skin. It retails for $160.00 and is available from physicians, spas and lifelineskincare.com. For more information, please visit http://www.lifelineskincare.com

About Lifeline Skin Care
Lifeline Skin Care develops, markets and sells advanced topical anti-aging skin care products based on technology developed and patented by International Stem Cell Corporation. The technology uses ingredients that have been extracted from ISCO’s human, parthenogenetic stem cells and are known to reduce the visible signs of skin aging. Lifeline is distributed in the USA and internationally through physicians and spas. For more information visit http://www.lifelineskincare.com

About International Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs) hence avoiding ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenetic, homozygous stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages and racial background with minimal immune rejection after transplantation. hpSCs offer the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology (http://www.lifelinecelltech.com), and stem cell-based skin care products through its subsidiary Lifeline Skin Care (http://www.lifelineskincare.com). More information is available at http://www.internationalstemcell.com.

PDF Print